This page contains affiliate links. We may earn a commission at no extra cost to you.

$80–$600 for home devices

Check Price on Amazon
Evidence: Moderate — growing body of peer-reviewed research, particularly in diabetic neuropathy and wound healing. Overlaps with the stronger near-infrared photobiomodulation literature. Multiple positive small-to-medium RCTs; larger multicenter trials ongoing.

Red light therapy (RLT), also known as photobiomodulation at the 620–700 nm wavelength range, uses specific low-power visible red light to penetrate the skin and stimulate cellular processes that may reduce inflammation, improve circulation, and support nerve fiber repair. Unlike near-infrared light (which penetrates more deeply), red wavelengths primarily affect the skin layers and superficial subcutaneous tissues — making them most relevant for the small nerve fibers in the skin that are affected in conditions like small fiber neuropathy and diabetic peripheral neuropathy. The evidence base for red light therapy in neuropathy is growing and overlaps significantly with the broader photobiomodulation literature. Many home devices combine red and near-infrared wavelengths to address both superficial and deeper nerve structures simultaneously. Discuss with your physician before starting.

How It Works

Red light at 620–680 nm is absorbed by cytochrome c oxidase in the mitochondrial electron transport chain — the same cellular target as near-infrared light. This absorption stimulates increased ATP production, reduces reactive oxygen species, and triggers a cascade of downstream effects including nitric oxide release (improving local microvascular blood flow), reduced inflammatory cytokine production, and activation of transcription factors involved in cellular repair and survival.

For peripheral nerve fibers specifically, the photobiomodulation effect may protect remaining nerve fibers from further degeneration through anti-apoptotic mechanisms and may support the regrowth of small fiber terminals through upregulation of nerve growth factor and brain-derived neurotrophic factor (BDNF). The intraepidermal nerve fibers (the thin endings that penetrate the top layers of skin and are measured in skin punch biopsy) are particularly accessible to red light wavelengths, making RLT a logical intervention for small fiber neuropathy in addition to larger-fiber peripheral neuropathy.

Clinical Evidence

Multiple randomized controlled trials and peer-reviewed studies have examined red and red/near-infrared combined photobiomodulation for peripheral neuropathy. A 2017 systematic review in Photomedicine and Laser Surgery reviewed 11 RCTs of low-level light therapy for diabetic neuropathy and found that the majority demonstrated significant pain reduction and improved sensory function compared to sham treatment. The review noted that combined red + near-infrared devices consistently outperformed single-wavelength devices, supporting multi-wavelength approaches.

A 2021 study published in the Journal of Diabetes Science and Technology evaluated a combined 660 nm and 850 nm LED pad device for plantar neuropathy and found significant improvements in pain VAS scores and monofilament sensation after 12 sessions. Several trials have also shown improvements in nerve conduction velocity parameters with photobiomodulation, suggesting effects beyond superficial symptom relief.

For small fiber neuropathy specifically, one pilot study demonstrated increased intraepidermal nerve fiber density on skin punch biopsy following photobiomodulation treatment — a finding suggesting actual nerve fiber regeneration rather than purely symptomatic benefit. Larger trials are needed to confirm this finding, but it represents a compelling direction for future research.

Home Use vs. Clinical Devices

Clinical-grade photobiomodulation devices used in research and medical practices typically deliver precise, calibrated doses measured in joules per square centimeter (J/cm²) and are designed for consistent, reproducible treatment. Home devices vary considerably in power output, beam uniformity, and build quality — making extrapolation from clinical device research to home device expectations imperfect.

For home use, the most important parameters are wavelength (660 nm red and 830–850 nm near-infrared are the best-studied for neuropathy), power density (mW/cm² — higher is not always better, but very low-powered devices are unlikely to deliver effective doses in reasonable treatment times), and build quality (consistent LED output, adequate heat dissipation). Devices marketed primarily as ‘red light therapy panels’ for general wellness vary enormously in these specifications — look for products from brands that publish irradiance data and have independent third-party testing.

Expect to invest $150 to $600 for a home device with meaningful photon delivery for neuropathy. Flexible foot wrap devices that conform to the plantar surface are preferable to flat panel devices for treating the soles of the feet — the most commonly symptomatic area.

Protocol — How to Use at Home

A practical home protocol for foot neuropathy using a combined red/near-infrared device: start with 10 to 20 minutes per foot (or both feet if the device accommodates them), five to seven times per week initially. Skin should be clean and free of lotions or sunscreen, which can absorb or scatter light before it reaches target tissue. Position the device as close to the skin as possible — most photobiomodulation research uses direct or near-direct contact application.

Track your symptoms using a simple 0–10 daily pain rating and note any changes in sensation, sleep quality, and foot temperature. Most protocols evaluate response at 4 to 8 weeks — if there is no measurable change in symptoms after 8 to 10 weeks of consistent daily use, photobiomodulation may not be the most effective approach for your specific neuropathy. As with all devices applied to areas of reduced sensation, inspect treated skin after each session for any signs of redness, irritation, or unusual skin changes.

Maintenance protocol after improvement: reduce frequency to three to four times per week and assess whether benefit is maintained. Some patients find benefit plateaus with continued daily use and that alternating daily sessions works equally well.

Pros

• Non-invasive, painless, with no known systemic side effects
• Multiple wavelengths of evidence — red light for superficial fibers, near-infrared for deeper structures
• Home devices make ongoing treatment convenient and cost-effective over time
• Evidence for both symptom reduction and possible nerve fiber regeneration
• Can be combined with other neuropathy treatments without interaction concerns

Cons

• Home device quality varies enormously — underpowered devices may not deliver effective doses
• Requires consistent daily use over weeks to months for meaningful results
• Not covered by Medicare or most insurance as a home treatment
• Risk of skin irritation or burns in areas with severely reduced sensation if device generates heat

Frequently Asked Questions

Is red light therapy the same as infrared light therapy?

They are closely related but distinct. Red light (620–700 nm) is visible and primarily affects the skin layers. Near-infrared light (700–1100 nm) is invisible and penetrates more deeply into tissue, reaching muscles, joints, and deeper nerve structures. Many effective photobiomodulation devices for neuropathy combine both wavelengths to address both superficial intraepidermal fibers and deeper nerve trunks simultaneously.

Can red light therapy be used alongside my neuropathy medications?

Yes — red light therapy works through photochemical cellular mechanisms that are independent of the pharmacological mechanisms of neuropathy medications. There are no known interactions. Some photosensitizing medications (certain antibiotics, St. John’s Wort) can increase light sensitivity in skin, so if you take any of these, consult your prescribing physician before starting.

How do I choose between a foot wrap device and a panel device for neuropathy?

Foot wrap or pad devices that conform to the plantar surface and toes deliver light to the areas typically most symptomatic in peripheral neuropathy, with better coverage than aiming a flat panel at the feet. Panel devices are more versatile (can treat legs, hands, and other areas) but may deliver less uniform light to the curved foot surface. If foot pain is your primary concern, a device designed for the foot specifically is worth the investment.

Is there a risk of skin damage from red light therapy?

Properly calibrated red and near-infrared LED devices do not emit ultraviolet (UV) radiation and do not cause the sunburn-type skin damage associated with UV exposure. At appropriate power levels, they do not heat tissue to damaging temperatures. However, devices that produce significant heat (above 104°F/40°C at the skin surface) can cause burns in patients with reduced sensation — always test the device on an area with normal sensation before applying to neuropathic feet.

Buy on Amazon — $80–$600 for home devices